A Prospective Study to Evaluate the Effect of CYP2D6 Polymorphism on Plasma level of Risperidone and its Metabolite in North Indian Patients with Schizophrenia

BACKGROUND: Risperidone is one of commonly utilized antipsychotic in clinical practice. Various metabolizing enzymes effect the plasma levels of risperidone and its active metabolite and thus its clinical efficacy. So, we attempted to evaluate the relationship between CYP2D6*10 (rs1065852) and CYP2D...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavan, Bir S., Kaur, Gurjit, Gupta, Deepti, Aneja, Jitender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065128/
https://www.ncbi.nlm.nih.gov/pubmed/30093744
http://dx.doi.org/10.4103/IJPSYM.IJPSYM_83_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065128/
https://www.ncbi.nlm.nih.gov/pubmed/30093744
http://dx.doi.org/10.4103/IJPSYM.IJPSYM_83_18

Ejemplares similares